ROYAL BIOLOGICS

Lobbying client · New Jersey · filed 2025 to 2026

OrthoBiologics and life science company

$110,000 Reported spend

4 Filings counted

1 Outside firm hired

3 Bills named

Spend is reported income plus in-house expenses across 4 filings. Everything on this page comes from one LDA client record (68274), filed by the registrant listed below.

Who filed for this client 1

THE MCMANUS GROUP $110,000 Outside firm · 4 filings

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

Bills named in these filings 3

S. 2561
Skin Substitute Access and Payment Reform Act of 2025

3 filings
H.R. 5768
Skin Substitute Access and Payment Reform Act

2 filings
H.R. 6852
Advanced Wound Care and Regenerative Medicine Access and Reform Act

2 filings

Reported by year 2 years

2026 $20,000 1 filing
2025 $90,000 3 filings

Issues lobbied 1

Medicare/Medicaid 4

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 4

HOUSE OF REPRESENTATIVES 3
SENATE 3
Centers For Medicare and Medicaid Services (CMS) 1
Health & Human Services, Dept of (HHS) 1

Recent filings 4 total

Q1 termination

THE MCMANUS GROUP

1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $20,000 income · posted Apr 20, 2026

View → Q4 report

THE MCMANUS GROUP

4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $50,000 income · posted Jan 20, 2026

View → Q3 report

THE MCMANUS GROUP

3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $40,000 income · posted Oct 20, 2025

View → Registration

THE MCMANUS GROUP

3rd Quarter 2025 (July 1 - Sep 30) · posted Aug 4, 2025

View →

Keep going

Filings through April 20, 2026, the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.